Fairfield, CT, United States of America

J Lucian Davis

This inventor holds 1 USPTO granted patent. Top assignees: Colorado State University Research Foundation, Leland Stanford Junior University, University of California. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Lucian Davis: Innovator in Mycobacterial Disease Treatment

Introduction

J Lucian Davis is a notable inventor based in Fairfield, CT (US). He has made significant contributions to the field of medical research, particularly in the treatment of mycobacterial diseases. His innovative approach has led to the development of methods that enhance the evaluation of treatment efficacy.

Latest Patents

Davis holds a patent titled "Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases." This invention provides novel markers of treatment response in subjects infected with mycobacteria, allowing for the quantification of treatment impact on the physiological state of the patient. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, J Lucian Davis has worked with esteemed institutions such as the Colorado State University Research Foundation and Leland Stanford Junior University. His work in these organizations has contributed to the advancement of research in mycobacterial diseases and treatment methodologies.

Collaborations

Davis has collaborated with notable colleagues, including Gary K Schoolnik and Gregory Dolganov. These partnerships have further enriched his research and innovation in the medical field.

Conclusion

J Lucian Davis stands out as an influential inventor in the realm of mycobacterial disease treatment. His innovative methods and collaborations have the potential to significantly impact patient care and treatment outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…